BioLineRx (BLRX) vs Phio Pharmaceuticals (PHIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BioLineRx (BLRX) has outperformed Phio Pharmaceuticals (PHIO) over the past year, losing 50.3% versus a loss of 57.5%. Over five years, BLRX leads with a -98.2% price change compared with -99.4% for PHIO. Phio Pharmaceuticals is the larger company by market cap ($11.6 million vs $11.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLRX | PHIO |
|---|---|---|
| Share price | $2.21 | $0.9995 |
| Market cap | $10.98M | $11.61M |
| 1-day change | -3.80% | +0.51% |
| YTD return | -20.40% | -4.81% |
| 1-year return | -50.34% | -57.47% |
| 5-year return | -98.20% | -99.45% |
| EPS (TTM) | $0.00 | $-1.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.50 | $4.19 |
| 52-week low | $2.15 | $0.813 |
| Distance from 52-week high | -51.00% | -76.15% |
| Average volume | 16.27K | 584.05K |
| Shares outstanding | 4.98M | 11.62M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
BLRX vs PHIO FAQ
Which is bigger, BioLineRx or Phio Pharmaceuticals?
Phio Pharmaceuticals (PHIO) is larger, with a market capitalization of $11.61M compared with $10.98M for BioLineRx (BLRX).
Which stock has performed better over the past year, BLRX or PHIO?
BLRX returned -50.34% over the past 12 months, compared with -57.47% for PHIO (price return, excluding dividends). Past performance does not predict future results.
Are BioLineRx and Phio Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.